Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1996-12-24
|
pubmed:abstractText |
In a retrospective study of 60 spindle-cell sarcomas of peripheral soft tissues, we evaluated the extent of immunostaining with antibodies against Ki-67, proliferating cell nuclear antigen, and p53 protein and flow-cytometric DNA ploidy, their relation to tumor location, depth, histologic type, size, mitotic rate, and extent of tumor necrosis, as well as their influence on survival. Although Ki-67-labeled nuclei were detected in only 41 tumors (68%) and their number varied from 1 to 50%, proliferating cell nuclear antigen immunoreactive nuclei were found in each tumor, with their number ranging from 20 to 99%. p53 Protein was found in 26 cases (43%), and its labeling ranged from 1 to 80%. Although Ki-67 labeling significantly correlated with mitotic rate, no correlation could be found between proliferating cell nuclear antigen or p53 labeling and any other variables studied. Thirty-eight percent of the tumors were diploid, and 64% were aneuploid. Factors that significantly reduced survival in univariate analysis were increasing size and depth of the tumor, the presence of necrosis, the National Cancer Institute grade, and a tetraploid/hypertetraploid DNA pattern. In multivariate analysis of 49 cases with complete information, only DNA ploidy pattern, tumor size, and tumor necrosis retained their independent prognostic significance.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Proliferating Cell Nuclear Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0893-3952
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
919-24
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8878024-Cell Division,
pubmed-meshheading:8878024-DNA, Neoplasm,
pubmed-meshheading:8878024-Flow Cytometry,
pubmed-meshheading:8878024-Humans,
pubmed-meshheading:8878024-Immunohistochemistry,
pubmed-meshheading:8878024-Ki-67 Antigen,
pubmed-meshheading:8878024-Multivariate Analysis,
pubmed-meshheading:8878024-Ploidies,
pubmed-meshheading:8878024-Prognosis,
pubmed-meshheading:8878024-Proliferating Cell Nuclear Antigen,
pubmed-meshheading:8878024-Retrospective Studies,
pubmed-meshheading:8878024-Sarcoma,
pubmed-meshheading:8878024-Soft Tissue Neoplasms,
pubmed-meshheading:8878024-Survival Analysis,
pubmed-meshheading:8878024-Tumor Markers, Biological,
pubmed-meshheading:8878024-Tumor Suppressor Protein p53
|
pubmed:year |
1996
|
pubmed:articleTitle |
Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas.
|
pubmed:affiliation |
Department of Pathology, Institute of Oncology, Ljubljana, Slovenia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|